Table 1:

BEAT2 Trial Scheme

	Time Period	Study Steps
Step 1	0 weeks	ART* + Baseline evaluation (innate response measures, leukapheresis /rectal biopsy, ophthalmic evaluation) Qualitative Interview [6]
Step 2	4 weeks	ART + Pegintron injections
Step 3	26 weeks	ATI + Pegintron injections + Broadly Neutralizing Antibodies Intravenous (IV) infusions
Step 4	12 weeks	ATI + Follow Up
Step 5	12 weeks	Return to ART, optional continued ATI Qualitative Interview

^*ART = Antiretroviral Therapy; ATI = Analytical Treatment Interruption